Paradoximmuno
Founded 2019 · 11 employees on LinkedIn · 3 known investors
Paradox develops a drug design platform to identify and create antibodies that selectively target misfolded, disease-causing proteins while leaving healthy proteins intact. The company focuses on treating protein misfolding diseases considered difficult to manage or incurable.
Investors · 3
Frequently asked questions
- What does Paradoximmuno do?
- Paradox develops a drug design platform to identify and create antibodies that selectively target misfolded, disease-causing proteins while leaving healthy proteins intact. The company focuses on treating protein misfolding diseases considered difficult to manage or incurable.
- Who are Paradoximmuno's investors?
- Paradoximmuno's investors include Beresford Ventures, Ontario Centre of Innovation, Ontario Centre of Innovation programs.